Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHL
2901
DELISTED
China Mobile Limited
CHL
| $5.13M | ﹤0.01% |
121,448
+88,639
| +270% | +$3.58M |
|
|
CBPO
2902
PUT
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $5.13M | ﹤0.01% |
44,100
-55,500
| -56% | -$6.43M |
|
2903
CALL
Precigen
PGEN
$2.52B
| $5.13M | ﹤0.01% |
935,500
-39,300
| -4% | -$221K |
|
2904
W.W. Grainger
GWW
$61.5B
| $5.12M | ﹤0.01% |
+15,130
| New | +$4.8M |
|
|
SAND
2905
PUT
DELISTED
Sandstorm Gold
SAND
| $5.11M | ﹤0.01% |
686,500
-99,500
| -13% | -$648K |
|
|
IMMU
2906
DELISTED
Immunomedics Inc
IMMU
| $5.11M | ﹤0.01% |
241,423
-173,368
| -42% | -$3.06M |
|
2907
Cencora
COR
$61.5B
| $5.11M | ﹤0.01% |
60,068
+30,223
| +101% | +$2.59M |
|
2908
Dover
DOV
$26.8B
| $5.11M | ﹤0.01% |
+44,295
| New | +$4.74M |
|
|
BRFS
2909
CALL
DELISTED
BRF SA
BRFS
| $5.1M | ﹤0.01% |
586,400
-208,300
| -26% | -$1.8M |
|
|
SGMO
2910
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.1M | ﹤0.01% |
609,200
-21,470
| -3% | -$197K |
|
2911
CALL
Flex
FLEX
$41.7B
| $5.1M | ﹤0.01% |
535,975
-2,787
| -0.5% | -$24K |
|
2912
Okta
OKTA
$30.1B
| $5.09M | ﹤0.01% |
44,160
-166,915
| -79% | -$19.2M |
|
|
EGRX
2913
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.09M | ﹤0.01% |
84,700
+72,600
| +600% | +$4.33M |
|
|
JNPR
2914
PUT
DELISTED
Juniper Networks
JNPR
| $5.09M | ﹤0.01% |
206,500
-88,500
| -30% | -$2.18M |
|
2915
CALL
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.32B
| $5.08M | ﹤0.01% |
+1
| New | +$6.87M |
|
2916
PUT
Tencent Music
TME
$14.1B
| $5.08M | ﹤0.01% |
432,800
-84,800
| -16% | -$1.09M |
|
|
DCPH
2917
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.08M | ﹤0.01% |
81,551
+43,734
| +116% | +$2.08M |
|
2918
iShares Global REIT ETF
REET
$5.01B
| $5.07M | ﹤0.01% |
183,500
+175,451
| +2,180% | +$4.92M |
|
2919
CDW
CDW
$18.8B
| $5.06M | ﹤0.01% |
35,417
+23,066
| +187% | +$3.05M |
|
2920
CALL
iRhythm Holdings
IRTC
$3.89B
| $5.06M | ﹤0.01% |
74,300
+64,700
| +674% | +$4.39M |
|
2921
CALL
InterDigital
IDCC
$8.65B
| $5.06M | ﹤0.01% |
92,800
+52,200
| +129% | +$2.88M |
|
|
TTM
2922
DELISTED
Tata Motors Limited
TTM
| $5.05M | ﹤0.01% |
390,975
-72,803
| -16% | -$802K |
|
2923
CALL
US Physical Therapy
USPH
$1.18B
| $5.05M | ﹤0.01% |
44,200
+1,800
| +4% | +$224K |
|
|
TGP
2924
DELISTED
Teekay LNG Partners L.P.
TGP
| $5.05M | ﹤0.01% |
324,804
-49,279
| -13% | -$727K |
|
2925
PUT
MasTec
MTZ
$19.9B
| $5.05M | ﹤0.01% |
78,700
-32,200
| -29% | -$2.12M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.